[1]
Kei A,Liberopoulos EN,Elisaf MS, What restricts the clinical use of nicotinic acid? Current vascular pharmacology. 2011 Jul 1; [PubMed PMID: 21314634]
[2]
Fricker RA,Green EL,Jenkins SI,Griffin SM, The Influence of Nicotinamide on Health and Disease in the Central Nervous System. International journal of tryptophan research : IJTR. 2018; [PubMed PMID: 29844677]
[3]
Goldberg RB,Jacobson TA, Effects of niacin on glucose control in patients with dyslipidemia. Mayo Clinic proceedings. 2008 Apr; [PubMed PMID: 18380993]
[4]
Wierzbicki AS, Niacin: the only vitamin that reduces cardiovascular events. International journal of clinical practice. 2011 Apr; [PubMed PMID: 21401825]
[5]
Florentin M,Liberopoulos EN,Kei A,Mikhailidis DP,Elisaf MS, Pleiotropic effects of nicotinic acid: beyond high density lipoprotein cholesterol elevation. Current vascular pharmacology. 2011 Jul 1; [PubMed PMID: 21314635]
[6]
HOFFER A, Treatment of arthritis by nicotinic acid and nicotinamide. Canadian Medical Association journal. 1959 Aug 15; [PubMed PMID: 14402370]
[7]
Xu XJ,Jiang GS, Niacin-respondent subset of schizophrenia – a therapeutic review. European review for medical and pharmacological sciences. 2015; [PubMed PMID: 25855923]
[8]
Taketani Y,Masuda M,Yamanaka-Okumura H,Tatsumi S,Segawa H,Miyamoto K,Takeda E,Yamamoto H, Niacin and Chronic Kidney Disease. Journal of nutritional science and vitaminology. 2015; [PubMed PMID: 26598845]
[9]
Park SM,Li T,Wu S,Li WQ,Weinstock M,Qureshi AA,Cho E, Niacin intake and risk of skin cancer in US women and men. International journal of cancer. 2017 May 1; [PubMed PMID: 28152570]
[10]
Motawi TK,Darwish HA,Hamed MA,El-Rigal NS,Aboul Naser AF, Coenzyme Q10 and niacin mitigate streptozotocin- induced diabetic encephalopathy in a rat model. Metabolic brain disease. 2017 Oct; [PubMed PMID: 28560538]
[11]
Gille A,Bodor ET,Ahmed K,Offermanns S, Nicotinic acid: pharmacological effects and mechanisms of action. Annual review of pharmacology and toxicology. 2008; [PubMed PMID: 17705685]
[12]
Montecucco F,Quercioli A,Dallegri F,Viviani GL,Mach F, New evidence for nicotinic acid treatment to reduce atherosclerosis. Expert review of cardiovascular therapy. 2010 Oct; [PubMed PMID: 20936932]
[15]
Li J,Qu J,Shi Y,Perfetto M,Ping Z,Christian L,Niu H,Mei S,Zhang Q,Yang X,Wei S, Nicotinic acid inhibits glioma invasion by facilitating Snail1 degradation. Scientific reports. 2017 Mar 3; [PubMed PMID: 28256591]
[16]
Yang X,Mei S,Niu H,Li J, Nicotinic acid impairs assembly of leading edge in glioma cells. Oncology reports. 2017 Aug; [PubMed PMID: 28656206]
[17]
Farnier M,Chen E,Johnson-Levonas AO,McCrary Sisk C,Mitchel YB, Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia. Vascular health and risk management. 2014; [PubMed PMID: 24855368]
[18]
Parhofer KG, Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia. Vascular health and risk management. 2009; [PubMed PMID: 20016845]
[19]
Goldie C,Taylor AJ,Nguyen P,McCoy C,Zhao XQ,Preiss D, Niacin therapy and the risk of new-onset diabetes: a meta-analysis of randomised controlled trials. Heart (British Cardiac Society). 2016 Feb; [PubMed PMID: 26370223]